TRIB vs. TKNO, VNRX, ABIO, ICCC, OCX, AWH, CDIO, BMRA, MYMD, and VRAX
Should you be buying Trinity Biotech stock or one of its competitors? The main competitors of Trinity Biotech include Alpha Teknova (TKNO), VolitionRx (VNRX), ARCA biopharma (ABIO), ImmuCell (ICCC), OncoCyte (OCX), Aspira Women's Health (AWH), Cardio Diagnostics (CDIO), Biomerica (BMRA), MyMD Pharmaceuticals (MYMD), and Virax Biolabs Group (VRAX). These companies are all part of the "diagnostic substances" industry.
Trinity Biotech (NASDAQ:TRIB) and Alpha Teknova (NASDAQ:TKNO) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, valuation, earnings, profitability, community ranking, media sentiment and analyst recommendations.
Trinity Biotech has higher revenue and earnings than Alpha Teknova. Alpha Teknova is trading at a lower price-to-earnings ratio than Trinity Biotech, indicating that it is currently the more affordable of the two stocks.
79.0% of Trinity Biotech shares are held by institutional investors. Comparatively, 13.8% of Alpha Teknova shares are held by institutional investors. 8.2% of Trinity Biotech shares are held by company insiders. Comparatively, 15.2% of Alpha Teknova shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Trinity Biotech has a net margin of -37.96% compared to Alpha Teknova's net margin of -97.85%. Trinity Biotech's return on equity of 0.00% beat Alpha Teknova's return on equity.
Trinity Biotech received 322 more outperform votes than Alpha Teknova when rated by MarketBeat users. Likewise, 71.74% of users gave Trinity Biotech an outperform vote while only 36.36% of users gave Alpha Teknova an outperform vote.
In the previous week, Alpha Teknova had 1 more articles in the media than Trinity Biotech. MarketBeat recorded 4 mentions for Alpha Teknova and 3 mentions for Trinity Biotech. Alpha Teknova's average media sentiment score of 0.87 beat Trinity Biotech's score of 0.29 indicating that Alpha Teknova is being referred to more favorably in the news media.
Alpha Teknova has a consensus price target of $5.00, indicating a potential upside of 22.55%. Given Alpha Teknova's higher probable upside, analysts plainly believe Alpha Teknova is more favorable than Trinity Biotech.
Trinity Biotech has a beta of 1.31, meaning that its stock price is 31% more volatile than the S&P 500. Comparatively, Alpha Teknova has a beta of 0.33, meaning that its stock price is 67% less volatile than the S&P 500.
Summary
Trinity Biotech beats Alpha Teknova on 9 of the 17 factors compared between the two stocks.
Get Trinity Biotech News Delivered to You Automatically
Sign up to receive the latest news and ratings for TRIB and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TRIB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Trinity Biotech Competitors List
Related Companies and Tools
Free TRIB Stock Alerts